Dehydration represents an important factor, as GLP-1 medications can cause nausea, vomiting, and diarrhea, particularly during dose escalation, leading to volume depletion
What an assessment involves A typical consultation includes: A focused history of your GLP-1 treatment (medication, dose, duration, rate of weight loss) Review of any symptoms, including subtle or partial ones Examination Review of any existing imaging Discussion of your individual risk profile, with the RELAPSTONE tool where appropriate A clear summary of the options, with no pressure to proceed If imaging is needed, this can be arranged
Many of these plaintiffs allege that they suffered medical hardship, financial burden, or emotional distress due to the drug and that they were not properly warned
placebo (68.8% vs